1st half 2019 sales: €14.871 million (-8.5% YoY) / +10% growth at Egide USA + Santier, +2.5% at constant exchange rate, with US HTCC sales more than doubling / Egide SA's sales (-29.4%) impacted by a tough market - Action plan launched to reorganize and optimize operations in France / H2 2019 Outlook: H1 order intake was €18.83 million (+23% YoY) with positive implications for H2 outlook: continued growth in the US and return to positive growth at Egide SA
